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Abstract (Word count: 200; Max 200) 
Objectives: To assess extent of electronic cigarette use by smokers attending Stop Smoking 
Services, the advice given about electronic cigarettes and whether this usage is recorded. 
Methods: Fifty-eight managers and 1284 practitioners completed an online survey. Questions 
covered use of electronic cigarettes, the advice given and whether use was recorded in client 
databases. 
Results: Ninety per cent (n = 1150) and 95% (n = 1215) of practitioners respectively, reported 
that their clients were using electronic cigarettes and that they had been asked about them. 
Seventy-one per cent (n = 41) of managers reported that they had a policy on the advice to be 
given; of whom 85% (n = 35) said that practitioners should say that products were unlicensed. 
Fifty-five per cent (n = 707) of practitioners reported giving such advice and 11% (n = 138) 
said they warned smokers about their safety. Only 9% (n = 119) reported that they recorded 
clients’ use. 
Conclusion: Although use of electronic cigarettes by smokers in Stop Smoking Services is 
common, few provisions are in place to record their use. Practitioners mostly advise that 
products are not licensed. 
Practical implications:There is a need to consider additional training for practitioners on use 
of e-cigarettes and harm reduction generally to ensure that advice is consistent and evidence-
based. 
 




The number of countries around the world offering some form of Stop Smoking Service to 
smokers who wish to quit is accumulating steadily, although these often differ extensively in 
structure and outreach [1]. Perhaps one of the most comprehensive is the United Kingdom 
Stop Smoking Services established in 1999, which have been instrumental in reducing 
smoking rates [2] and have served as a model for other countries. These services are under the 
direction of local authorities, with each configuring itself on the basis of national guidelines. 
The services aim to provide evidence-based behavioural support and access to smoking 
cessation medication [3,4].  
With the release of the National Institute of Health and Care Excellence guidance on tobacco 
harm reduction in June 2013, the English Stop Smoking Services may be extended to offer 
support and guidance to smokers who are unable or unwilling to stop smoking [5]. The 
guidance covers two main forms of harm reduction - smoking reduction and temporary 
abstinence - which have both been shown to increase the propensity of smokers to stop, 
particularly if supported by licenced nicotine containing products [6-8]. Although this advice 
may take many forms, one recommendation is that guidance on harm reduction is incorporated 
into the brief advice given by health-care professionals prior to service attendance. This will 
reduce disruption to the current services and ensure the message is still that of complete 
abstinence [9]. However, smokers attempting harm reduction should be encourage to attend 
the services when they feel ready to quit smoking and given support to stop abruptly (Note: 
although clinical trials have found that gradual cessation has similar efficacy as abrupt 
cessation, it appears to be less effective in the real world [see 10-12]). 
The National Institute of Clinical and Care Excellence guidance also acknowledged the 
potential contribution of electronic cigarettes (e-cigarettes) to tobacco harm reduction, but 
would only advocate this approach if they became licenced medicines in the UK. Studies have 
shown that these devices are becoming increasingly popular, and that they may help users to 
reduce or quit smoking [13-20]. They also deliver clinically significant levels of nicotine into 
the blood, albeit, at least for some smokers, at a much lower level than traditional tobacco 
products [21-23]. Potentially harmful constituents have been identified in some cartridges 
[24,25]; though levels are much lower than those found in cigarettes [26].  
However, a major limitation with many of these studies is that they were based on surveys 
which recruited smokers from e-cigarette forums who are likely to hold more favourable 
attitudes towards such products. This is evident in the study by Dawkins et al [23], where the 
authors reported that 74% of their sample had not smoked for several weeks since using e-
cigarettes. This far exceeds what would be expected for currently available efficacious 
treatments [27]. Much of the data thus far on safety and nicotine intake is also based on clinical 
trials, thus results may not play out in the real world where smokers will not generally be 
provided with e-cigarettes free of charge.  
In June 2013, the Medicines and Healthcare products Regulatory Agency finalised their 
consultation on e-cigarettes and reached the decision that they should be regulated as 
medicines in the UK by 2016, in the belief that licensing would improve their safety and 
effectiveness [28]. This has put the UK at the forefront of the debate on e-cigarettes, with 
many other countries deliberating over their use or banning/imposing heavy restrictions, 
including Australia, Brazil, Lebanon, France, US and Singapore. Reasons for this hostility 
include the belief that they contain harmful substances, that they may encourage higher 
consumption of nicotine and that they will act as a gateway to smoking. 
With the release of guidelines on harm reduction, and these regulatory changes to e-cigarettes, 
there is a need to determine the role that Stop Smoking Services will play. A first step, and 
the aim of this paper, is to ascertain the procedures stop smoking practitioners and managers 
have in place to record and advise smokers about the use of electronic cigarettes and to assess 
their beliefs about the prevalence and reasons for e-cigarette use among their clients.  
It is important to discover whether Stop Smoking Services have provisions in place to record 
e-cigarette use, since careful monitoring will allow for the analysis of the impact of e-
cigarettes on quit rates over time and other significant clinical outcomes. It might be 
hypothesised that since they are not currently licensed, and therefore not available on 
prescription, that few if any monitoring procedures will be implemented. It is similarly 
important to determine the advice given by Stop Smoking Practitioners to ensure that the Stop 
Smoking Services are maintaining an evidence-based approach; since although there is strong 
endorsement for evidence-based practice in health-care fields, its use is often lacking [29-32].  
One reason for this is that health-care professionals’ personal beliefs often conflict with the 
evidence base and are more likely to influence practice [33-35]. For example, previous 
research shows that health-care professionals hold erroneous views about nicotine containing 
products and harm reduction generally, and that these beliefs are associated with the advice 
offered to smokers [36,37]. Thus if similar views are established about e-cigarettes it is 
plausible that Stop Smoking Practitioners may advise against their use. This situation may 
change in the UK in light of the recent guidance and recommendations by National Institute 
of Clinical and Care Excellence and the Medicines and Healthcare products Regulatory 
Agency, and with training on e-cigarettes and harm reduction offered to Stop Smoking 
Practitioners by organisations such as the National Centre for Smoking Cessation and 
Training.   
Finally, it is of interest to assess their beliefs about how many clients are using e-cigarettes 
and the reasons for their use, in order to inform future polices and the training offered to Stop 
Smoking Practitioners. Previous research suggests that smokers use e-cigarettes as they are 
less toxic than tobacco, to quit smoking or avoid relapsing, to deal with cravings for tobacco, 
during periods of temporary abstinence, for smoking reduction, and because they are cheaper 
than cigarettes [14,15]. If a substantial proportion of e-cigarette users are attempting harm 
reduction then the prevalence of use in Stop Smoking Services may be low, on the basis that 
smokers who use nicotine containing products for harm reduction often do not approach 
health-care professionals and hold hostile beliefs about the services offered to smokers 
[38,39].  
The specific questions addressed by the current study are as follows: 
1. Do stop smoking services have procedures in place to record clients’ cigarette use? 
2. What advice do stop smoking practitioners give their clients about e-cigarettes and is 
this consistent with the recommendations given by managers of stop smoking services? 
3. How many clients have asked questions about e-cigarettes, tried them, or report 
regularly using them? 




An email was sent to all Stop Smoking Managers in England on behalf of the researchers by 
the National Centre for Smoking Cessation and Training. All managers were requested to take 
part and to forward the link to their staff. An email was also sent to all Stop Smoking 
Practitioners on the National Centre for Smoking Cessation and Training database and to all 
those that completed the 2011 survey but were not on the training database. Emails were 
personalised where possible i.e. addressed practitioners and managers by name. Reminders 
were sent 1 and 2 weeks following the initial request. The online survey was open between 
the 4th of December 2012 and 4th of January 2013. As an incentive for participation, all those 
who completed the survey were entered into a prize draw for a place and accommodation at 
the 2013 UK National Smoking Cessation Conference worth £450.  
 
Measures 
The manager and practitioner survey comprised of 44 and 59 questions respectively. This 
paper reports on the subset of questions on e-cigarettes. These questions were developed by a 
group of researchers working in the area of tobacco harm reduction and e-cigarette use. 
Question design was informed by prior research, with the intention being to keep questions as 
clear and concise as possible, and to provide response categorises which covered the most 
common answers but allowed open-ended responses [40]. Standard ethical guidelines were 
followed: participants could withdraw at any time, all data was anonymised and the burden of 
study participation minimized by keeping the questionnaire as brief as possible.  
Stop Smoking Managers were asked three questions about e-cigarettes: 1) Does your service 
have a system in place to record use of electronic cigarettes (e-cigarettes)? [Yes, No]; 2) Does 
your service have a recommendation of what advice practitioners should give on e-cigarettes? 
[Yes, No]; 3) If yes, what is the recommended advice on e-cigarettes? [Free text box of 500 
characters].  
Practitioners were asked six questions about electronic cigarettes: 1) What proportion of the 
clients you have seen this year (2012) have asked you questions about electronic cigarettes (e-
cigarettes)? [None, Less than a quarter, From a quarter to a half, From a half to three quarters, 
More than three quarters]; 2) What proportion of the clients you have seen this year says they 
have ever used e-cigarettes? [None, Less than a quarter, From a quarter to a half, From a half 
to three quarters, More than three quarters]; 3) What proportion of the clients you have seen 
this year report regularly using e-cigarettes? [None, Less than a quarter, From a quarter to a 
half, From a half to three quarters, More than three quarters]; 4) Of your clients who have 
used e-cigarettes or are currently using them what have they used them for? [To try to quit, 
When they were unable to smoke, To help them cut down the number of cigarettes they are 
smoking, As an alternative to smoking, To get rid of the smell of stale smoke, To protect their 
health, To protect the health of those around them; To see what they were like, Other (please 
state)]; 5) What advice do you give about e-cigarettes? [Free text box of 500 characters]; 6) 
Does your service have a system in place to record use of e-cigarettes? [Yes, No]. 
 
Analysis 
Prior to the analysis, open-ended questions were coded into categorises using a thematic text 
analysis [41], derived from the procedures used by Hruschka et al [42] on HIV behavioural 
research. This involved three stages: 1) segmentation of text, 2) casebook creation, and 3) 
coding. The lead coder coded the text and then sent a sample to the second coder, with 
inconsistencies discussed and clarifications to the codebook made in response. The process 
continued until a Cohen Kappa of 0.8 was established. In total 50% of the text was coded by 
both coders. Differences between managers and practitioners who completed and did not 
complete the survey were assessed with chi-square and t-test analyses. 
 
3. Results 
One hundred and fifty-five managers were contacted, of which 82.6%% (n=128) agreed to 
participate in the online survey. Of these, 70 were excluded as they terminated the survey 
early and did not reach the questions on e-cigarettes. This resulted in a final sample of 58 
managers (37.4% response rate). Seventy-eight per cent (n=45) of managers were female. The 
majority were employed by a Primary Care Trust or Hospital Trust (39.7%, n=23) and on 
average had managed a Stop Smoking Service for 6.8 (SD+ 3.78) years. There was no 
evidence that those who completed the survey differed to those who dropped out in terms of 
gender (X2=0.46, df=1, p=0.500) or whether they were employed by a Primary Care 
Trust/Hospital or other organisation (X2=0.94, df=1, p=0.332). However, those who 
completed the survey had worked for an average of 1.5 years longer (t=-2.12, df=96, p=0.37). 
In total, 2,420 responses were recorded for the practitioners’ survey. A response rate could 
not be calculated because currently it is not known how many practitioners work in the English 
Stop Smoking Services, or how many were forwarded and received the invitation. Of these, 
249 (10.3%) were excluded as the respondents reported that they did not see smokers on behalf 
of English Stop Smoking Services and 887 (36.7%) were excluded as they did not reach the 
questions on e-cigarettes. This resulted in a final sample of 1,284 practitioners (53.1% 
response rate). The majority were female (85.8%, n=1102). Practitioners had worked for a 
mean of 7.0 (SD+ 4.37) years. Thirty-six per cent (n=460) were specialist Stop Smoking 
Practitioners (i.e. a practitioner whose main role involves providing smoking cessation 
support, as opposed to a community practitioner for whom smoking cessation is a small part 
of their job). There was no evidence that those who completed the survey differed to those 
who dropped out in terms of gender (X2=0.04, df=1, p=0.845) and length of time having 
worked for (t=-0.03, df=2,084, p=0.978). However, they were more likely to be specialist 
practitioners (X2=42.89, df=1, p<0.001). 
Table 1 shows that the majority of service managers do not have a system in place to record 
e-cigarette use by clients, however, a substantial proportion do offer specific 
recommendations as to what practitioners should inform smokers about. In the majority of 
cases (85.4%), this advice was along the lines that e-cigarettes are currently not approved by 
the Medicines and Healthcare products Regulatory Agency or National Institute of Clinical 
and Care Excellence and that more research is required before they can give guidance about 
them.  
Table 2 shows that a large proportion of practitioners have been asked about e-cigarettes by 
their clients in the past year, with only 5.4% of practitioners having had no clients enquire 
about them while 11.1% were asked by more than three-quarters of their clients. A substantial 
number of clients also appear to be using e-cigarettes, with only 10.4% of practitioners 
reporting that none of their clients have tried them. In terms of regular use, 19.8% of 
practitioners report that 50% or more of their clients use e-cigarettes on a regular basis. The 
main reasons that practitioners believed their clients used e-cigarettes were to quit smoking 
(71.0%), to help them cut down (49.9%) and for periods of temporary abstinence (28.6%)(see 
Table 2). In line with the findings from the managers’ survey, very few practitioners reported 
that systems were in place to record e-cigarette use. The main advice given was that e-
cigarettes were not yet approved/there was a lack of research to provide guidance (55.1%). 
 
4. Discussion and conclusion 
4.1 Discussion 
The current study found that few Stop Smoking Services have systems in place to record e-
cigarette use, but that a large majority of service managers do provide practitioners with 
recommendations as to the advice they should give smokers about e-cigarettes. Common 
advice included that e-cigarettes are not currently approved or licensed and more research is 
required on their efficacy and safety. The actual advice that practitioners gave their clients 
was similar, except many also raised safety concerns. Surprisingly, the vast majority of 
practitioners reported that they had been asked questions about e-cigarettes and that their 
clients had tried or used them regularly. Use of e-cigarettes by clients for harm reduction was 
common. 
It is perhaps unsurprising that few Stop Smoking Services have provisions in place to record 
the use of e-cigarettes among their clients, since these products are not licensed medications 
and as such are not available on prescription. However, given that a large number of smokers 
are now using these devices, and the Medicines and Healthcare products Regulatory Agency 
have called for licensing by 2016, Services should consider implementing procedures to 
record prevalence and extent of use among their clients. In fact, careful monitoring of e-
cigarette use and the association with clinical outcomes was one of the main research 
objectives outlined by the National Institute of Clinical and Care Excellence guidance on harm 
reduction. The National Centre for Smoking Cessation and Training has already incorporated 
e-cigarette use into their Client Record Forms [43], while the UK National Smoking Cessation 
Conference this year widely encouraged monitoring by health-care professionals [44]. 
However, the 2012/2013 ‘Stop Smoking Service: monitoring and guidance update’ failed to 
acknowledge the use of e-cigarettes [45]. 
The advice being given to clients appeared to be largely evidence-based and followed the 
guidelines provided by service managers i.e. the majority of practitioners informed smokers 
that the products were not currently licensed for smoking cessation or harm reduction and that 
further research was required. However, a substantial proportion of practitioners also actively 
discouraged their use due to safety concerns. These concerns were generally along two lines: 
1) stories that e-cigarettes could easily combust or explode and 2) that they contained 
compounds which were carcinogenic. These two points are not evidence-based. A recent study 
showed that the compounds in e-cigarettes are 9-450 times lower than the levels found in 
traditional cigarettes, and are comparable to the levels found in currently licensed nicotine 
containing products [26] and while it is the case that there are instances of e-cigarettes 
exploding, this occurs at a risk level similar to that for household goods. 
Finally, it is perhaps surprising that so many practitioners have come across smokers who 
have tried or use e-cigarettes frequently, with a substantial minority reporting that nearly all 
their clients use e-cigarettes on a regular basis. These products as such appear to have high 
customer appeal, despite other nicotine containing products being available either at a lower 
price or for free depending on individual circumstance. One reason for this may be that 
smokers find traditional nicotine containing products unsatisfying [39], since they are 
designed to minimize the risks of abuse and dependence [46], or that this is simply a novelty 
effect. West, DiMarino and McNeill [47] reported an initial increase in use of the nicotine 
lozenge on its introduction to the UK market. However its use has since declined in favour of 
other products (e.g. the Nicotine patch)[6].  
Although this study offers valuable data on the current place of e-cigarettes within Stop 
Smoking Services, a number of limitations need to be considered. First, no objective data were 
available on clinical practice. It may be the case that smokers fail to convey their use of e-
cigarettes to practitioners, thus resulting in practitioners underestimating the frequency of use 
or incorrectly reporting the reasons for use. Secondly, the response rate was quite low for the 
Stop Smoking Managers survey, thus the sample attained may not be representative of Stop 
Smoking Mangers in general. One reason for this may have been the timing of recruitment 
which was during the winter holiday period [48], although stop smoking services are open 
regularly during this time. Fourthly, the effect of drop-out may have resulted in an 
unrepresentative sample. This is evidenced by the finding that mangers who completed the 
survey had worked for a longer period of time, while practitioners who dropped out were less 
likely to be specialists. It may be the case that more experienced managers have better 
provisions in place to record e-cigarette use, but then again newer managers may be more 
likely to keep abreast with current research. Finally, the current study was based on English 
Stop Smoking Services. It is possible that the findings will not apply to other countries that 
have less liberal views on harm reduction and e-cigarettes. This would be a useful area for 
future research.  
 
4.2 Practice implications 
Despite a large majority of smokers attending Stop Smoking Services being interested in 
and/or are using e-cigarettes, nearly 1/3rd of services do not provide practitioners with advice 
on what they should tell smokers. Mangers should be encouraged to keep up-to-date with 
developments in tobacco control and ensure that their services are providing consistent non-
contradictory and accurate information. This can be achieved by providing practitioners with 
the necessary resources to undertake regular update training. Detailed information about e-
cigarettes should also be incorporated into training programmes for other health-care 
professionals who come into contact with smokers. In fact, it is likely that pharmacists and 
physicians will be the first point of call for many smokers using these products.  
On the basis of current research, health-care professionals should be advised to inform 
smokers that some e-cigarettes are likely to be licensed by 2016 as medicinal smoking 
cessation aids; evidence suggests they are substantially safer than traditional cigarettes but 
further research is required to assess their effectiveness and safety profile; and that in the 
meantime they may wish instead to use currently licensed nicotine containing products, but 
the choice should be theirs.  
The difficulty will be ensuring adherence to these guidelines given that previous studies have 
shown that only 60% of the content of stop smoking manuals provided to practitioners is 
communicated with fidelity in practice [49]. Moreover, providing information to practitioners 
in countries which do not offer structured training is likely to be an arduous task [1]. Article 
14 of the 2005 World Health Organisation Framework goes someway in addressing this, by 
requiring parties to take effective measures to promote cessation of tobacco use and adequate 
treatment for tobacco dependence. The basic infrastructure elements include national training 
standards, mandatory reporting of tobacco use in all medical notes, a national cessation 
strategy and access to affordable medications and specialised tobacco dependence treatment 
services [50].  
In addition to offering training to practitioners it should be recognized that factors other than 
knowledge and beliefs are important in ensuring that the guidelines and recommendations put 
forward by on e-cigarettes are implemented. Michie et al [33] identified a number of domains 
and related constructs which should be considered during the process of developing 
interventions to increase evidence-based practice. From this it could be argued that 
practitioners should not only receive training and information on the guidance, but should be 
encouraged to implement it, provided with an environment which is suitable for 
implementation, have access to the necessary tools, should receive prompts to remind them 
about the guidance, and reinforcement and praise for implementation. It should also be 
ensured that there is commitment from managerial levels and that any implementation does 
not conflict with current goals or create cognitive overload. Clearly this will be a difficult 
process in a climate of budget cuts, an ultimate goal to create a smoke-free society, and lack 
of time and resources. Thus it is important to consider carefully how and to what extent these 
guidelines are adopted by Stop Smoking Services. 
 
4.3 Conclusion 
A substantial number of smokers who attend Stop Smoking Services are now enquiring about 
e-cigarettes or report using them regularly for both smoking cessation and harm reduction. 
Few services have provisions in place to record use; nonetheless, a large proportion of Stop 
Smoking Practitioners offer advice and guidance on their use. In the majority of cases this 
advice is evidence-based and follows the recommendations of Stop Smoking Service 
Managers. However, there is some variability in the advice given, with a substantial minority 
of practitioners actively discouraging smokers from using the devices due to unsubstantiated 
safety concerns.  
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